Notably, L34 showed a trend to reduce total form of IS and endotoxin but did not reach a significant level (p = 0.16) (Fig. 1 J), possibly due to the short duration of probiotic treatment and limited number of patients.
← all excerpts
Lacticaseibacillus rhamnosus attenuates uremic toxins in patients with nondialysis chronic kidney disease through the anti-inflammatory molecules.
1
—
—